As a neurologist with more than 30 years in the field of Alzheimer’s disease, I have had many heartbreaking conversations with patients and their loved ones. More than 6 million people in America are living with Alzheimer’s disease, and that staggering number is expected to double within the next 30 years unless there is a change. However, I am more optimistic about that change and physicians’ ability to slow the course of this devastating illness than I have ever been in the past.

Approved in 2016, the newly updated label changes add more clarity to the use of pimavanserin, noting that patients with Parkinson disease with dementia may be eligible for treatment.

Dietitians reveal exactly how giving up a nightcap will better your health.

Leafy vegetable and whole berry supplementation-based dietary counseling improved the metabolic pathways involved in the pathogensis and prognosis and of gestinational diabetes mellitus, a recent study published in Nutrients has shown.  

H-bombs use a combination of nuclear fission and fusion and are far more powerful than atomic bombs.

Seven years after the end of WWII, the US detonated the world's first hydrogen bomb.

The world's first nuclear weapon — the atom bomb — devastated the Japanese cities of Hiroshima and Nagasaki in 1945.

Clinicians from Switzerland are urging caution when prescribing an anti-amyloid medication in a patient with Alzheimer's disease (AD) also taking a selective serotonin reuptake inhibitor (SSRI) antidepressant.

Who doesn't like to find a bowl full of juicy strawberries when they open the fridge? Strawberries are one of the most appreciated fruits in gastronomy due to their exquisite flavor, but we rarely consider their healthy qualities when enjoying them. However, these fruits have an extensive list of benefits, some of which have been scientifically supported in recent studies.

Strawberries, blueberries and blackberries share beneficial properties for memory

A new immunotherapy candidate has demonstrated a trend for slowing cognitive decline in mild Alzheimer’s disease (AD), potentially offering a more accessible and cost-effective alternative to other immunotherapies.

It could also help prevent diseases such as Alzheimer's or diabetes.